{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:42:59Z","timestamp":1794008579123,"version":"4.8.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008713","name":"Diabetes Australia Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition, Metabolism and Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recent advances in genome-wide approaches, the availability of isolated human islets for research and the evaluation of novel incretin mimetics in large clinical trials have brought about remarkable progress in our understanding of the role of the pancreatic beta cell in type 2 diabetes. Here, we review key developments in type 2 diabetes initiation, progression and remission, focusing mostly on human studies published in the last 5 years. Progress in multi-omics technologies has enabled researchers to identify links between type 2 diabetes risk variants and gene regulatory networks in islet endocrine cells that control beta cell development, function and stress resilience. These studies support the notion that early abnormalities in insulin secretion, rather than a reduction in beta cell mass, play a fundamental and primary role in early type 2 diabetes pathogenesis. Contributing to these intrinsic beta cell defects are various pathogenic signals from other (endocrine and non-endocrine) islet cells, the exocrine pancreas, the gut and insulin-sensitive tissues. It has also become apparent that beta cells comprise a heterogeneous population that responds differently to stress situations and that sex-related differences in beta cell responses should not be underestimated. Finally, human clinical trials have clearly demonstrated that diabetes remission can be achieved using glucose-lowering therapies and particularly strategies focused on weight loss, including bariatric surgery and, more recently, the use of highly efficient new drugs targeting the incretin system. While progress in the last 5 years has been significant, much remains to be uncovered to bring these advances to the clinic and thereby alleviate the dramatic consequences of type 2 diabetes complications for the hundreds of millions of people who live with this disease.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s00125-025-06499-z","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:20:47Z","timestamp":1754479247000},"page":"2092-2103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The role of the beta cell in type 2 diabetes: new findings from the last 5 years"],"prefix":"10.1007","volume":"68","author":[{"given":"Belinda","family":"Yau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ghislain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-7378","authenticated-orcid":false,"given":"Melkam A.","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-8175","authenticated-orcid":false,"given":"Jing","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6555-5053","authenticated-orcid":false,"given":"Vincent","family":"Poitout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"10","key":"6499_CR1","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00125-020-05245-x","volume":"63","author":"N Esser","year":"2020","unstructured":"Esser N, Utzschneider KM, Kahn SE (2020) Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia 63(10):2007\u20132021. https:\/\/doi.org\/10.1007\/s00125-020-05245-x","journal-title":"Diabetologia"},{"issue":"10","key":"6499_CR2","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s00125-021-05505-4","volume":"64","author":"JD Johnson","year":"2021","unstructured":"Johnson JD (2021) On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes. Diabetologia 64(10):2138\u20132146. https:\/\/doi.org\/10.1007\/s00125-021-05505-4","journal-title":"Diabetologia"},{"issue":"2","key":"6499_CR3","doi-asserted-by":"publisher","first-page":"109807","DOI":"10.1016\/j.celrep.2021.109807","volume":"37","author":"L Alonso","year":"2021","unstructured":"Alonso L, Piron A, Moran I et al (2021) TIGER: The gene expression regulatory variation landscape of human pancreatic islets. Cell Rep 37(2):109807. https:\/\/doi.org\/10.1016\/j.celrep.2021.109807","journal-title":"Cell Rep"},{"issue":"7","key":"6499_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","volume":"52","author":"M Vujkovic","year":"2020","unstructured":"Vujkovic M, Keaton JM, Lynch JA et al (2020) Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 52(7):680\u2013691. https:\/\/doi.org\/10.1038\/s41588-020-0637-y","journal-title":"Nat Genet"},{"issue":"4","key":"6499_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41574-020-0325-0","volume":"16","author":"NAJ Krentz","year":"2020","unstructured":"Krentz NAJ, Gloyn AL (2020) Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics. Nat Rev Endocrinol 16(4):202\u2013212. https:\/\/doi.org\/10.1038\/s41574-020-0325-0","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"6499_CR6","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1038\/s41598-021-99091-5","volume":"11","author":"AM Deaton","year":"2021","unstructured":"Deaton AM, Parker MM, Ward LD et al (2021) Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes. Sci Rep 11(1):21565. https:\/\/doi.org\/10.1038\/s41598-021-99091-5","journal-title":"Sci Rep"},{"issue":"46","key":"6499_CR7","doi-asserted-by":"publisher","first-page":"eadd5430","DOI":"10.1126\/sciadv.add5430","volume":"8","author":"A Nag","year":"2022","unstructured":"Nag A, Dhindsa RS, Mitchell J et al (2022) Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci Adv 8(46):eadd5430. https:\/\/doi.org\/10.1126\/sciadv.add5430","journal-title":"Sci Adv"},{"issue":"7886","key":"6499_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A et al (2021) Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599(7886):628\u2013634. https:\/\/doi.org\/10.1038\/s41586-021-04103-z","journal-title":"Nature"},{"issue":"10","key":"6499_CR9","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s42255-024-01140-6","volume":"6","author":"AL Madsen","year":"2024","unstructured":"Madsen AL, Bonas-Guarch S, Gheibi S et al (2024) Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology. Nat Metab 6(10):1897\u20131912. https:\/\/doi.org\/10.1038\/s42255-024-01140-6","journal-title":"Nat Metab"},{"issue":"4","key":"6499_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng.2915","volume":"46","author":"J Flannick","year":"2014","unstructured":"Flannick J, Thorleifsson G, Beer NL et al (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46(4):357\u2013363. https:\/\/doi.org\/10.1038\/ng.2915","journal-title":"Nat Genet"},{"issue":"11","key":"6499_CR11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s41588-019-0513-9","volume":"51","author":"OP Dwivedi","year":"2019","unstructured":"Dwivedi OP, Lehtovirta M, Hastoy B et al (2019) Loss of ZnT8 function protects against diabetes by enhanced insulin secretion. Nat Genet 51(11):1596\u20131606. https:\/\/doi.org\/10.1038\/s41588-019-0513-9","journal-title":"Nat Genet"},{"issue":"7","key":"6499_CR12","doi-asserted-by":"publisher","first-page":"e40972","DOI":"10.1371\/journal.pone.0040972","volume":"7","author":"LD Pound","year":"2012","unstructured":"Pound LD, Sarkar SA, Ustione A et al (2012) The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PloS one 7(7):e40972. https:\/\/doi.org\/10.1371\/journal.pone.0040972","journal-title":"PloS one"},{"issue":"1","key":"6499_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JOE-21-0271","volume":"253","author":"M Karsai","year":"2022","unstructured":"Karsai M, Zuellig RA, Lehmann R et al (2022) Lack of ZnT8 protects pancreatic islets from hypoxia- and cytokine-induced cell death. J Endocrinol 253(1):1\u201311. https:\/\/doi.org\/10.1530\/JOE-21-0271","journal-title":"J Endocrinol"},{"issue":"4","key":"6499_CR14","doi-asserted-by":"publisher","first-page":"e163612","DOI":"10.1172\/JCI163612","volume":"133","author":"K Bacos","year":"2023","unstructured":"Bacos K, Perfilyev A, Karagiannopoulos A et al (2023) Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. J Clin Investig 133(4):e163612. https:\/\/doi.org\/10.1172\/JCI163612","journal-title":"J Clin Investig"},{"issue":"1","key":"6499_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41588-022-01261-2","volume":"55","author":"AK Rottner","year":"2023","unstructured":"Rottner AK, Ye Y, Navarro-Guerrero E et al (2023) A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk. Nat Genet 55(1):54\u201365. https:\/\/doi.org\/10.1038\/s41588-022-01261-2","journal-title":"Nat Genet"},{"issue":"3","key":"6499_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina DL, Di Paola S, Peluso I et al (2015) Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 17(3):288\u2013299. https:\/\/doi.org\/10.1038\/ncb3114","journal-title":"Nat Cell Biol"},{"issue":"6","key":"6499_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2337\/dbi20-0014","volume":"70","author":"GL Pearson","year":"2021","unstructured":"Pearson GL, Gingerich MA, Walker EM, Biden TJ, Soleimanpour SA (2021) A selective look at autophagy in pancreatic beta-cells. Diabetes 70(6):1229\u20131241. https:\/\/doi.org\/10.2337\/dbi20-0014","journal-title":"Diabetes"},{"issue":"8","key":"6499_CR18","doi-asserted-by":"publisher","first-page":"114640","DOI":"10.1016\/j.celrep.2024.114640","volume":"43","author":"SJ Kaplan","year":"2024","unstructured":"Kaplan SJ, Wong W, Yan J et al (2024) CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant. Cell Rep 43(8):114640. https:\/\/doi.org\/10.1016\/j.celrep.2024.114640","journal-title":"Cell Rep"},{"issue":"11","key":"6499_CR19","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/db23-0498","volume":"72","author":"J Russ-Silsby","year":"2023","unstructured":"Russ-Silsby J, Patel KA, Laver TW et al (2023) The role of ONECUT1 variants in monogenic and type 2 diabetes mellitus. Diabetes 72(11):1729\u20131734. https:\/\/doi.org\/10.2337\/db23-0498","journal-title":"Diabetes"},{"issue":"11","key":"6499_CR20","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.cmet.2024.09.006","volume":"36","author":"EK Sokolowski","year":"2024","unstructured":"Sokolowski EK, Kursawe R, Selvam V et al (2024) Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights. Cell Metab 36(11):2468-2488 e2467. https:\/\/doi.org\/10.1016\/j.cmet.2024.09.006","journal-title":"Cell Metab"},{"issue":"1","key":"6499_CR21","doi-asserted-by":"publisher","first-page":"8040","DOI":"10.1038\/s41467-023-43719-9","volume":"14","author":"T R\u00f6nn","year":"2023","unstructured":"R\u00f6nn T, Ofori JK, Perfilyev A et al (2023) Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes. Nat Commun 14(1):8040. https:\/\/doi.org\/10.1038\/s41467-023-43719-9","journal-title":"Nat Commun"},{"issue":"1","key":"6499_CR22","doi-asserted-by":"publisher","first-page":"107469","DOI":"10.1016\/j.celrep.2020.03.033","volume":"31","author":"CM Cohrs","year":"2020","unstructured":"Cohrs CM, Panzer JK, Drotar DM et al (2020) Dysfunction of persisting \u03b2 cells is a key feature of early type 2 diabetes pathogenesis. Cell Rep 31(1):107469. https:\/\/doi.org\/10.1016\/j.celrep.2020.03.033","journal-title":"Cell Rep"},{"issue":"11","key":"6499_CR23","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2337\/db23-0130","volume":"72","author":"RM Elgamal","year":"2023","unstructured":"Elgamal RM, Kudtarkar P, Melton RL et al (2023) An integrated map of cell type-specific gene expression in pancreatic islets. Diabetes 72(11):1719\u20131728. https:\/\/doi.org\/10.2337\/db23-0130","journal-title":"Diabetes"},{"issue":"10","key":"6499_CR24","doi-asserted-by":"publisher","first-page":"100763","DOI":"10.1016\/j.xcrm.2022.100763","volume":"3","author":"K Diamanti","year":"2022","unstructured":"Diamanti K, Cavalli M, Pereira MJ et al (2022) Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues. Cell Rep Med 3(10):100763. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100763","journal-title":"Cell Rep Med"},{"issue":"1","key":"6499_CR25","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1038\/s41467-023-38148-7","volume":"14","author":"RC Slieker","year":"2023","unstructured":"Slieker RC, Donnelly LA, Akalestou E et al (2023) Identification of biomarkers for glycaemic deterioration in type 2 diabetes. Nat Commun 14(1):2533. https:\/\/doi.org\/10.1038\/s41467-023-38148-7","journal-title":"Nat Commun"},{"issue":"9","key":"6499_CR26","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","volume":"64","author":"RC Slieker","year":"2021","unstructured":"Slieker RC, Donnelly LA, Fitipaldi H et al (2021) Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia 64(9):1982\u20131989. https:\/\/doi.org\/10.1007\/s00125-021-05490-8","journal-title":"Diabetologia"},{"issue":"1","key":"6499_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13098-021-00690-z","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang H, Cao J, Su JB et al (2021) Serum fatty acid-binding protein 4 levels and responses of pancreatic islet beta-cells and alpha-cells in patients with type 2 diabetes. Diabetol Metab Syndr 13(1):70. https:\/\/doi.org\/10.1186\/s13098-021-00690-z","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"6499_CR28","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.2337\/db23-0761","volume":"73","author":"LK Billings","year":"2024","unstructured":"Billings LK, Jablonski KA, Pan Q et al (2024) Increased genetic risk for beta-cell failure is associated with beta-cell function decline in people with prediabetes. Diabetes 73(8):1352\u20131360. https:\/\/doi.org\/10.2337\/db23-0761","journal-title":"Diabetes"},{"issue":"5","key":"6499_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cmet.2020.04.005","volume":"31","author":"J Camunas-Soler","year":"2020","unstructured":"Camunas-Soler J, Dai XQ, Hang Y et al (2020) Patch-Seq links single-cell transcriptomes to human islet dysfunction in diabetes. Cell Metab 31(5):1017-1031.e1014. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.005","journal-title":"Cell Metab"},{"issue":"10","key":"6499_CR30","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/dbi20-0001","volume":"69","author":"E Ahlqvist","year":"2020","unstructured":"Ahlqvist E, Prasad RB, Groop L (2020) Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69(10):2086\u20132093. https:\/\/doi.org\/10.2337\/dbi20-0001","journal-title":"Diabetes"},{"issue":"5","key":"6499_CR31","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","volume":"432","author":"M Lytrivi","year":"2020","unstructured":"Lytrivi M, Castell AL, Poitout V, Cnop M (2020) Recent insights into mechanisms of \u03b2-cell lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol 432(5):1514\u20131534. https:\/\/doi.org\/10.1016\/j.jmb.2019.09.016","journal-title":"J Mol Biol"},{"issue":"3","key":"6499_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2337\/dbi19-0014","volume":"69","author":"M Prentki","year":"2020","unstructured":"Prentki M, Peyot ML, Masiello P, Madiraju SRM (2020) Nutrient-induced metabolic stress, adaptation, detoxification, and toxicity in the pancreatic \u03b2-cell. Diabetes 69(3):279\u2013290. https:\/\/doi.org\/10.2337\/dbi19-0014","journal-title":"Diabetes"},{"issue":"3","key":"6499_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2337\/db19-0138","volume":"69","author":"GC Weir","year":"2020","unstructured":"Weir GC (2020) Glucolipotoxicity, \u03b2-cells, and diabetes: the emperor has no clothes. Diabetes 69(3):273\u2013278. https:\/\/doi.org\/10.2337\/db19-0138","journal-title":"Diabetes"},{"issue":"9","key":"6499_CR34","doi-asserted-by":"publisher","first-page":"108466","DOI":"10.1016\/j.celrep.2020.108466","volume":"33","author":"L Marselli","year":"2020","unstructured":"Marselli L, Piron A, Suleiman M et al (2020) Persistent or transient human \u03b2 cell dysfunction induced by metabolic stress: specific signatures and shared gene expression with type 2 diabetes. Cell Rep 33(9):108466. https:\/\/doi.org\/10.1016\/j.celrep.2020.108466","journal-title":"Cell Rep"},{"issue":"5","key":"6499_CR35","doi-asserted-by":"publisher","first-page":"109919","DOI":"10.1016\/j.celrep.2021.109919","volume":"37","author":"M Wu","year":"2021","unstructured":"Wu M, Lee MYY, Bahl V et al (2021) Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry. Cell Rep 37(5):109919. https:\/\/doi.org\/10.1016\/j.celrep.2021.109919","journal-title":"Cell Rep"},{"key":"6499_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.coph.2018.08.002","volume":"43","author":"M Lytrivi","year":"2018","unstructured":"Lytrivi M, Igoillo-Esteve M, Cnop M (2018) Inflammatory stress in islet beta-cells: therapeutic implications for type 2 diabetes? Curr Opin Pharmacol 43:40\u201345. https:\/\/doi.org\/10.1016\/j.coph.2018.08.002","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"6499_CR37","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1038\/s41467-024-49724-w","volume":"15","author":"MM Maestas","year":"2024","unstructured":"Maestas MM, Ishahak M, Augsornworawat P et al (2024) Identification of unique cell type responses in pancreatic islets to stress. Nat Commun 15(1):5567. https:\/\/doi.org\/10.1038\/s41467-024-49724-w","journal-title":"Nat Commun"},{"issue":"1","key":"6499_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41574-023-00898-1","volume":"20","author":"G Xourafa","year":"2024","unstructured":"Xourafa G, Korbmacher M, Roden M (2024) Inter-organ crosstalk during development and progression of type 2 diabetes mellitus. Nat Rev Endocrinol 20(1):27\u201349. https:\/\/doi.org\/10.1038\/s41574-023-00898-1","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"6499_CR39","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2337\/db24-0177","volume":"73","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Qian B, Yang Y et al (2024) Visceral adipocyte-derived extracellular vesicle miR-27a-5p elicits glucose intolerance by inhibiting pancreatic \u03b2-cell insulin secretion. Diabetes 73(11):1832\u20131847. https:\/\/doi.org\/10.2337\/db24-0177","journal-title":"Diabetes"},{"issue":"1","key":"6499_CR40","doi-asserted-by":"publisher","first-page":"2111951","DOI":"10.1080\/19490976.2022.2111951","volume":"14","author":"TPM Scheithauer","year":"2022","unstructured":"Scheithauer TPM, Herrema H, Yu H et al (2022) Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction. Gut Microbes 14(1):2111951. https:\/\/doi.org\/10.1080\/19490976.2022.2111951","journal-title":"Gut Microbes"},{"issue":"1","key":"6499_CR41","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1038\/s41467-024-46829-0","volume":"15","author":"L Kong","year":"2024","unstructured":"Kong L, Zhao Q, Jiang X et al (2024) Trimethylamine N-oxide impairs beta-cell function and glucose tolerance. Nat Commun 15(1):2526. https:\/\/doi.org\/10.1038\/s41467-024-46829-0","journal-title":"Nat Commun"},{"issue":"7","key":"6499_CR42","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmet.2023.05.007","volume":"35","author":"G Basile","year":"2023","unstructured":"Basile G, Vetere A, Hu J et al (2023) Excess pancreatic elastase alters acinar-\u03b2 cell communication by impairing the mechano-signaling and the PAR2 pathways. Cell Metab 35(7):1242-1260.e1249. https:\/\/doi.org\/10.1016\/j.cmet.2023.05.007","journal-title":"Cell Metab"},{"issue":"12","key":"6499_CR43","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.cmet.2022.09.013","volume":"34","author":"SN Shapira","year":"2022","unstructured":"Shapira SN, Naji A, Atkinson MA, Powers AC, Kaestner KH (2022) Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program. Cell Metab 34(12):1906\u20131913. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.013","journal-title":"Cell Metab"},{"issue":"7612","key":"6499_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature18624","volume":"535","author":"E Bader","year":"2016","unstructured":"Bader E, Migliorini A, Gegg M et al (2016) Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature 535(7612):430\u2013434. https:\/\/doi.org\/10.1038\/nature18624","journal-title":"Nature"},{"issue":"11","key":"6499_CR45","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s42255-024-01097-6","volume":"6","author":"GA Rutter","year":"2024","unstructured":"Rutter GA, Gresch A, Delgadillo Silva L, Benninger RKP (2024) Exploring pancreatic beta-cell subgroups and their connectivity. Nat Metab 6(11):2039\u20132053. https:\/\/doi.org\/10.1038\/s42255-024-01097-6","journal-title":"Nat Metab"},{"issue":"5","key":"6499_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cmet.2023.03.008","volume":"35","author":"E Dror","year":"2023","unstructured":"Dror E, Fagnocchi L, Wegert V et al (2023) Epigenetic dosage identifies two major and functionally distinct \u03b2 cell subtypes. Cell Metab 35(5):821-836.e827. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.008","journal-title":"Cell Metab"},{"key":"6499_CR47","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1038\/ncomms11756","volume":"7","author":"C Dorrell","year":"2016","unstructured":"Dorrell C, Schug J, Canaday PS et al (2016) Human islets contain four distinct subtypes of beta cells. Nat Commun 7:11756. https:\/\/doi.org\/10.1038\/ncomms11756","journal-title":"Nat Commun"},{"issue":"4","key":"6499_CR48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41588-021-00823-0","volume":"53","author":"J Chiou","year":"2021","unstructured":"Chiou J, Zeng C, Cheng Z et al (2021) Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk. Nat Genet 53(4):455\u2013466. https:\/\/doi.org\/10.1038\/s41588-021-00823-0","journal-title":"Nat Genet"},{"issue":"1","key":"6499_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13073-023-01179-2","volume":"15","author":"RB Kang","year":"2023","unstructured":"Kang RB, Li Y, Rosselot C et al (2023) Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes beta-cell subpopulations with dynamic transcriptome profiles. Genome Med 15(1):30. https:\/\/doi.org\/10.1186\/s13073-023-01179-2","journal-title":"Genome Med"},{"issue":"1","key":"6499_CR50","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/s41467-024-47686-7","volume":"15","author":"J Lehrstrand","year":"2024","unstructured":"Lehrstrand J, Davies WIL, Hahn M, Korsgren O, Alanentalo T, Ahlgren U (2024) Illuminating the complete ss-cell mass of the human pancreas- signifying a new view on the islets of Langerhans. Nat Commun 15(1):3318. https:\/\/doi.org\/10.1038\/s41467-024-47686-7","journal-title":"Nat Commun"},{"issue":"4","key":"6499_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41556-023-01103-1","volume":"25","author":"A Rubio-Navarro","year":"2023","unstructured":"Rubio-Navarro A, Gomez-Banoy N, Stoll L et al (2023) A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes. Nat Cell Biol 25(4):565\u2013578. https:\/\/doi.org\/10.1038\/s41556-023-01103-1","journal-title":"Nat Cell Biol"},{"issue":"6","key":"6499_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41588-023-01397-9","volume":"55","author":"G Wang","year":"2023","unstructured":"Wang G, Chiou J, Zeng C et al (2023) Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetes. Nat Genet 55(6):984\u2013994. https:\/\/doi.org\/10.1038\/s41588-023-01397-9","journal-title":"Nat Genet"},{"issue":"1","key":"6499_CR53","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/s41467-023-41228-3","volume":"14","author":"C Weng","year":"2023","unstructured":"Weng C, Gu A, Zhang S et al (2023) Single cell multiomic analysis reveals diabetes-associated \u03b2-cell heterogeneity driven by HNF1A. Nat Commun 14(1):5400. https:\/\/doi.org\/10.1038\/s41467-023-41228-3","journal-title":"Nat Commun"},{"issue":"7","key":"6499_CR54","doi-asserted-by":"publisher","first-page":"e2206797120","DOI":"10.1073\/pnas.2206797120","volume":"120","author":"HJ Taylor","year":"2023","unstructured":"Taylor HJ, Hung YH, Narisu N et al (2023) Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis. Proc Natl Acad Sci U S A 120(7):e2206797120. https:\/\/doi.org\/10.1073\/pnas.2206797120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6499_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2337\/db21-0077","volume":"71","author":"JK Ofori","year":"2022","unstructured":"Ofori JK, Karagiannopoulos A, Nagao M et al (2022) Human islet microRNA-200c is elevated in type 2 diabetes and targets the transcription factor ETV5 to reduce insulin secretion. Diabetes 71(2):275\u2013284. https:\/\/doi.org\/10.2337\/db21-0077","journal-title":"Diabetes"},{"issue":"7","key":"6499_CR56","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2337\/db21-0803","volume":"71","author":"R Cheung","year":"2022","unstructured":"Cheung R, Pizza G, Chabosseau P et al (2022) Glucose-dependent miR-125b is a negative regulator of beta-cell function. Diabetes 71(7):1525\u20131545. https:\/\/doi.org\/10.2337\/db21-0803","journal-title":"Diabetes"},{"issue":"5","key":"6499_CR57","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2337\/db20-0553","volume":"70","author":"A Midha","year":"2021","unstructured":"Midha A, Pan H, Abarca C et al (2021) Unique human and mouse \u03b2-cell Senescence-Associated Secretory Phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes 70(5):1098\u20131116. https:\/\/doi.org\/10.2337\/db20-0553","journal-title":"Diabetes"},{"issue":"2","key":"6499_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/jc.2015-3566","volume":"101","author":"AE Butler","year":"2016","unstructured":"Butler AE, Dhawan S, Hoang J et al (2016) Beta-cell deficit in obese type 2 diabetes, a minor role of Beta-cell dedifferentiation and degranulation. J Clin Endocrinol Metab 101(2):523\u2013532. https:\/\/doi.org\/10.1210\/jc.2015-3566","journal-title":"J Clin Endocrinol Metab"},{"key":"6499_CR59","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.molmet.2020.101057","volume":"42","author":"D Avrahami","year":"2020","unstructured":"Avrahami D, Wang YJ, Schug J et al (2020) Single-cell transcriptomics of human islet ontogeny defines the molecular basis of \u03b2-cell dedifferentiation in T2D. Mol Metab 42:101057. https:\/\/doi.org\/10.1016\/j.molmet.2020.101057","journal-title":"Mol Metab"},{"issue":"1","key":"6499_CR60","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-024-06475-0","volume":"7","author":"J Wang","year":"2024","unstructured":"Wang J, Wen S, Chen M et al (2024) Regulation of endocrine cell alternative splicing revealed by single-cell RNA sequencing in type 2 diabetes pathogenesis. Commun Biol 7(1):778. https:\/\/doi.org\/10.1038\/s42003-024-06475-0","journal-title":"Commun Biol"},{"issue":"12","key":"6499_CR61","doi-asserted-by":"publisher","first-page":"e172436","DOI":"10.1172\/JCI172436","volume":"134","author":"MW Haemmerle","year":"2024","unstructured":"Haemmerle MW, Scota AV, Khosravifar M et al (2024) RNA-binding protein PCBP2 regulates pancreatic \u03b2 cell function and adaptation to glucose. J Clin Investig 134(12):e172436. https:\/\/doi.org\/10.1172\/JCI172436","journal-title":"J Clin Investig"},{"issue":"1","key":"6499_CR62","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1038\/s41467-023-43605-4","volume":"14","author":"ND Moss","year":"2023","unstructured":"Moss ND, Wells KL, Theis A et al (2023) Modulation of insulin secretion by RBFOX2-mediated alternative splicing. Nat Commun 14(1):7732. https:\/\/doi.org\/10.1038\/s41467-023-43605-4","journal-title":"Nat Commun"},{"issue":"3","key":"6499_CR63","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","volume":"53","author":"F Mauvais-Jarvis","year":"2004","unstructured":"Mauvais-Jarvis F, Sobngwi E, Porcher R et al (2004) Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 53(3):645\u2013653. https:\/\/doi.org\/10.2337\/diabetes.53.3.645","journal-title":"Diabetes"},{"issue":"2","key":"6499_CR64","doi-asserted-by":"publisher","first-page":"109813","DOI":"10.1016\/j.celrep.2021.109813","volume":"37","author":"EM Walker","year":"2021","unstructured":"Walker EM, Cha J, Tong X et al (2021) Sex-biased islet beta cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males. Cell Rep 37(2):109813. https:\/\/doi.org\/10.1016\/j.celrep.2021.109813","journal-title":"Cell Rep"},{"issue":"24","key":"6499_CR65","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1038\/s44318-024-00313-z","volume":"43","author":"MMF Qadir","year":"2024","unstructured":"Qadir MMF, Elgamal RM, Song K et al (2024) Sex-specific regulatory architecture of pancreatic islets from subjects with and without type 2 diabetes. EMBO J 43(24):6364\u20136382. https:\/\/doi.org\/10.1038\/s44318-024-00313-z","journal-title":"EMBO J"},{"key":"6499_CR66","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.molmet.2023.101678","volume":"69","author":"GP Brownrigg","year":"2023","unstructured":"Brownrigg GP, Xia YH, Chu CMJ et al (2023) Sex differences in islet stress responses support female \u03b2 cell resilience. Mol Metab 69:101678. https:\/\/doi.org\/10.1016\/j.molmet.2023.101678","journal-title":"Mol Metab"},{"issue":"9","key":"6499_CR67","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2337\/diacare.20.9.1353","volume":"20","author":"H Ilkova","year":"1997","unstructured":"Ilkova H, Glaser B, Tun\u00e7kale A, Bagria\u00e7ik N, Cerasi E (1997) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 20(9):1353\u20131356. https:\/\/doi.org\/10.2337\/diacare.20.9.1353","journal-title":"Diabetes Care"},{"issue":"11","key":"6499_CR68","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","volume":"27","author":"Y Li","year":"2004","unstructured":"Li Y, Xu W, Liao Z et al (2004) Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 27(11):2597\u20132602. https:\/\/doi.org\/10.2337\/diacare.27.11.2597","journal-title":"Diabetes Care"},{"issue":"1","key":"6499_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1463-1326.2009.01129.x","volume":"12","author":"R Retnakaran","year":"2010","unstructured":"Retnakaran R, Yakubovich N, Qi Y, Opsteen C, Zinman B (2010) The response to short-term intensive insulin therapy in type 2 diabetes. Diabetes Obes Metab 12(1):65\u201371. https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01129.x","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"6499_CR70","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.2337\/diacare.27.5.1028","volume":"27","author":"EA Ryan","year":"2004","unstructured":"Ryan EA, Imes S, Wallace C (2004) Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 27(5):1028\u20131032. https:\/\/doi.org\/10.2337\/diacare.27.5.1028","journal-title":"Diabetes Care"},{"issue":"1","key":"6499_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/en.2006-0738","volume":"148","author":"Q Huang","year":"2007","unstructured":"Huang Q, Bu S, Yu Y et al (2007) Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2\/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology 148(1):81\u201391. https:\/\/doi.org\/10.1210\/en.2006-0738","journal-title":"Endocrinology"},{"issue":"1","key":"6499_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1677\/JOE-08-0251","volume":"199","author":"E Sargsyan","year":"2008","unstructured":"Sargsyan E, Orts\u00e4ter H, Thorn K, Bergsten P (2008) Diazoxide-induced beta-cell rest reduces endoplasmic reticulum stress in lipotoxic beta-cells. J Endocrinol 199(1):41\u201350. https:\/\/doi.org\/10.1677\/JOE-08-0251","journal-title":"J Endocrinol"},{"issue":"4","key":"6499_CR73","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1210\/jc.2017-01838","volume":"103","author":"H Al Jobori","year":"2018","unstructured":"Al Jobori H, Daniele G, Adams J et al (2018) Empagliflozin treatment is associated with improved \u03b2-cell function in type 2 diabetes mellitus. J Clin Endocrinol Metab 103(4):1402\u20131407. https:\/\/doi.org\/10.1210\/jc.2017-01838","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6499_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2337\/db18-0304","volume":"68","author":"BB Boland","year":"2019","unstructured":"Boland BB, Brown C, Boland ML et al (2019) Pancreatic \u03b2-cell rest replenishes insulin secretory capacity and attenuates diabetes in an extreme model of obese type 2 diabetes. Diabetes 68(1):131\u2013140. https:\/\/doi.org\/10.2337\/db18-0304","journal-title":"Diabetes"},{"issue":"5","key":"6499_CR75","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jmb.2019.08.014","volume":"432","author":"DA Jacobson","year":"2020","unstructured":"Jacobson DA, Shyng SL (2020) Ion channels of the islets in type 2 diabetes. J Mol Biol 432(5):1326\u20131346. https:\/\/doi.org\/10.1016\/j.jmb.2019.08.014","journal-title":"J Mol Biol"},{"key":"6499_CR76","doi-asserted-by":"publisher","first-page":"3975147","DOI":"10.1155\/2022\/3975147","volume":"2022","author":"GM Matos","year":"2022","unstructured":"Matos GM, Andersson B, Islam MS (2022) Expression of transient receptor potential channel genes and their isoforms in alpha-cells and beta-cells of human islets of Langerhans. J Diabetes Res 2022:3975147. https:\/\/doi.org\/10.1155\/2022\/3975147","journal-title":"J Diabetes Res"},{"issue":"12","key":"6499_CR77","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.2337\/db22-0004","volume":"71","author":"M Gosak","year":"2022","unstructured":"Gosak M, Yan-Do R, Lin H, MacDonald PE, Stozer A (2022) Ca2+ oscillations, waves, and networks in islets from human donors with and without type 2 diabetes. Diabetes 71(12):2584\u20132596. https:\/\/doi.org\/10.2337\/db22-0004","journal-title":"Diabetes"},{"issue":"1","key":"6499_CR78","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1038\/s41467-023-39978-1","volume":"14","author":"YT Yeh","year":"2023","unstructured":"Yeh YT, Sona C, Yan X et al (2023) Restoration of PITPNA in type 2 diabetic human islets reverses pancreatic beta-cell dysfunction. Nat Commun 14(1):4250. https:\/\/doi.org\/10.1038\/s41467-023-39978-1","journal-title":"Nat Commun"},{"issue":"11","key":"6499_CR79","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Group DPPR","year":"2015","unstructured":"Group DPPR (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3(11):866\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(15)00291-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"6499_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","volume":"8","author":"S Taheri","year":"2020","unstructured":"Taheri S, Zaghloul H, Chagoury O et al (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 8(6):477\u2013489. https:\/\/doi.org\/10.1016\/S2213-8587(20)30117-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"6499_CR81","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","volume":"54","author":"EL Lim","year":"2011","unstructured":"Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54(10):2506\u20132514. https:\/\/doi.org\/10.1007\/s00125-011-2204-7","journal-title":"Diabetologia"},{"issue":"1","key":"6499_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7861\/clinmedicine.19-1-37","volume":"19","author":"R Taylor","year":"2019","unstructured":"Taylor R (2019) Calorie restriction for long-term remission of type 2 diabetes. Clin Med (Lond) 19(1):37\u201342. https:\/\/doi.org\/10.7861\/clinmedicine.19-1-37","journal-title":"Clin Med (Lond)"},{"issue":"10120","key":"6499_CR83","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet (London, England) 391(10120):541\u2013551. https:\/\/doi.org\/10.1016\/S0140-6736(17)33102-1","journal-title":"Lancet (London, England)"},{"issue":"4","key":"6499_CR84","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","volume":"12","author":"ME Lean","year":"2024","unstructured":"Lean ME, Leslie WS, Barnes AC et al (2024) 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol 12(4):233\u2013246. https:\/\/doi.org\/10.1016\/S2213-8587(23)00385-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"6499_CR85","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2018.08.010","volume":"28","author":"R Taylor","year":"2018","unstructured":"Taylor R, Al-Mrabeh A, Zhyzhneuskaya S et al (2018) Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery. Cell Metab 28(4):667. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.010","journal-title":"Cell Metab"},{"issue":"4","key":"6499_CR86","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/dc19-0371","volume":"43","author":"SV Zhyzhneuskaya","year":"2020","unstructured":"Zhyzhneuskaya SV, Al-Mrabeh A, Peters C et al (2020) Time course of normalization of functional \u03b2-cell capacity in the diabetes remission clinical trial after weight loss in type 2 diabetes. Diabetes Care 43(4):813\u2013820. https:\/\/doi.org\/10.2337\/dc19-0371","journal-title":"Diabetes Care"},{"issue":"8","key":"6499_CR87","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2024.0318","volume":"331","author":"AP Courcoulas","year":"2024","unstructured":"Courcoulas AP, Patti ME, Hu B et al (2024) Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes. JAMA 331(8):654\u2013664. https:\/\/doi.org\/10.1001\/jama.2024.0318","journal-title":"JAMA"},{"issue":"12","key":"6499_CR88","doi-asserted-by":"publisher","first-page":"e170307","DOI":"10.1172\/jci.insight.170307","volume":"8","author":"B Mittendorfer","year":"2023","unstructured":"Mittendorfer B, Patterson BW, Magkos F et al (2023) \u03b2 Cell function after Roux-en-Y gastric bypass surgery or reduced energy intake alone in people with obesity. JCI Insight 8(12):e170307. https:\/\/doi.org\/10.1172\/jci.insight.170307","journal-title":"JCI Insight"},{"issue":"1","key":"6499_CR89","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/s41467-021-25423-8","volume":"12","author":"E Akalestou","year":"2021","unstructured":"Akalestou E, Suba K, Lopez-Noriega L et al (2021) Intravital imaging of islet Ca 2+ dynamics reveals enhanced \u03b2 cell connectivity after bariatric surgery in mice. Nat Commun 12(1):5165. https:\/\/doi.org\/10.1038\/s41467-021-25423-8","journal-title":"Nat Commun"},{"issue":"8","key":"6499_CR90","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s00125-017-4289-0","volume":"60","author":"C Kapitza","year":"2017","unstructured":"Kapitza C, Dahl K, Jacobsen JB, Axelsen MB, Flint A (2017) Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial. Diabetologia 60(8):1390\u20131399. https:\/\/doi.org\/10.1007\/s00125-017-4289-0","journal-title":"Diabetologia"},{"issue":"1","key":"6499_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2023.24945","volume":"331","author":"LJ Aronne","year":"2024","unstructured":"Aronne LJ, Sattar N, Horn DB et al (2024) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA 331(1):38\u201348. https:\/\/doi.org\/10.1001\/jama.2023.24945","journal-title":"JAMA"},{"issue":"Supplement_1","key":"6499_CR92","doi-asserted-by":"publisher","first-page":"266-OR","DOI":"10.2337\/db24-266-OR","volume":"73","author":"J Rosenstock","year":"2024","unstructured":"Rosenstock J, Coskun T, Hartman ML et al (2024) Retatrutide, an agonist of GIP, GLP-1, and glucagon receptors, improves markers of pancreatic beta-cell function and insulin sensitivity. Diabetes 73(Supplement_1):266-OR. https:\/\/doi.org\/10.2337\/db24-266-OR","journal-title":"Diabetes"},{"issue":"1","key":"6499_CR93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dbi20-0018","volume":"73","author":"CM Cohrs","year":"2024","unstructured":"Cohrs CM, Chen C, Atkinson MA, Drotar DM, Speier S (2024) Bridging the gap: pancreas tissue slices from organ and tissue donors for the study of diabetes pathogenesis. Diabetes 73(1):11\u201322. https:\/\/doi.org\/10.2337\/dbi20-0018","journal-title":"Diabetes"},{"issue":"11","key":"6499_CR94","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.stem.2024.08.007","volume":"31","author":"L Yang","year":"2024","unstructured":"Yang L, Han Y, Zhang T et al (2024) Human vascularized macrophage-islet organoids to model immune-mediated pancreatic beta cell pyroptosis upon viral infection. Cell Stem Cell 31(11):1612-1629 e1618. https:\/\/doi.org\/10.1016\/j.stem.2024.08.007","journal-title":"Cell Stem Cell"},{"key":"6499_CR95","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.molmet.2023.101772","volume":"76","author":"B Blanchi","year":"2023","unstructured":"Blanchi B, Taurand M, Colace C et al (2023) EndoC-\u03b2H5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol Metab 76:101772. https:\/\/doi.org\/10.1016\/j.molmet.2023.101772","journal-title":"Mol Metab"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06499-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:04:41Z","timestamp":1757498681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06499-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":95,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6499"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06499-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. Work in the Kebede laboratory is supported by Diabetes Australia Research Trust and the National Health and Medical Research Council of Australia. Work in the Hughes laboratory is supported by the US National Institutes of Health. Work in the Poitout laboratory is supported by the US National Institutes of Health, the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and Diabetes Canada.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}